SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 193 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $572,000 | +0.5% | 7,626 | +4.7% | 0.29% | -9.8% |
Q1 2022 | $569,000 | +55.9% | 7,285 | +48.6% | 0.32% | -51.8% |
Q1 2021 | $365,000 | +54.0% | 4,902 | +146.8% | 0.66% | +391.0% |
Q1 2019 | $237,000 | -52.9% | 1,986 | -36.3% | 0.13% | -38.8% |
Q3 2018 | $503,000 | +146.6% | 3,117 | -30.7% | 0.22% | +277.6% |
Q3 2017 | $204,000 | -47.4% | 4,500 | -65.6% | 0.06% | -63.3% |
Q1 2017 | $388,000 | – | 13,100 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |